These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2480633

  • 21. [Serum markers in malignant diseases].
    Peter HH.
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract] [Full Text] [Related]

  • 22. Biological markers of human tumors and monitoring of cancer treatment.
    Tanneberger S, Nissen E, Ziegenbein R.
    Arch Geschwulstforsch; 1979 Nov; 49(6):528-34. PubMed ID: 94534
    [Abstract] [Full Text] [Related]

  • 23. [Tumor markers. Current knowledge and practical usefulness].
    Papaleo G, Sacerdoti G, Zito GA.
    Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
    Seliuzhitskiĭ IV, Skvortsov SV, Lytsar' BN.
    Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
    [No Abstract] [Full Text] [Related]

  • 30. [Tumor markers. Current use in antineoplastic strategy].
    Manguso L, Musset M, Coraggio F, Grimaldi G, Zito GA, Gattoni A, Catalano G, Astarita C, Papaleo G, Di Domenico M.
    Clin Ter; 1984 Aug 15; 110(3):231-41. PubMed ID: 6207976
    [No Abstract] [Full Text] [Related]

  • 31. Tumor markers in testis tumors.
    Kansu E.
    Turk J Pediatr; 1984 Aug 15; 26(1-4):277-83. PubMed ID: 6085661
    [No Abstract] [Full Text] [Related]

  • 32. Tumour markers in ovarian cancer.
    van Nagell JR.
    Clin Obstet Gynaecol; 1983 Aug 15; 10(2):197-212. PubMed ID: 6193919
    [No Abstract] [Full Text] [Related]

  • 33. [Usefulness of tumor markers in hepatogastroenterology].
    Rougier P, Ychou M, Bidart JM, Bellet D.
    Gastroenterol Clin Biol; 1989 Aug 15; 13(2 Pt 3):T1-5. PubMed ID: 2470632
    [No Abstract] [Full Text] [Related]

  • 34. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
    Edwards JC, Moon CR.
    Immunol Ser; 1990 Aug 15; 53():95-106. PubMed ID: 1713073
    [Abstract] [Full Text] [Related]

  • 35. Biochemical and immunochemical markers associated with cancer.
    Schwartz MK.
    Clin Bull; 1976 Aug 15; 6(2):62-8. PubMed ID: 59641
    [No Abstract] [Full Text] [Related]

  • 36. Altered glycoprotein sugar-chain structures as possible diagnostic and prognostic markers in malignant tumors.
    Yoshida K, Sumi S, Yano M, Suzuki T, Ueda Y.
    Int J Urol; 1995 Nov 15; 2(5):281-7. PubMed ID: 8749945
    [No Abstract] [Full Text] [Related]

  • 37. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E, Kovács L, Szabolcs I, Rimanóczy E, Czirják S, Góth M.
    Orv Hetil; 2002 Mar 24; 143(12):601-5. PubMed ID: 11963397
    [Abstract] [Full Text] [Related]

  • 38. [New clinical tests: current status of tumor markers].
    Imai K, Taniuchi A.
    Nihon Naika Gakkai Zasshi; 1993 Apr 10; 82(4):554-7. PubMed ID: 7688018
    [No Abstract] [Full Text] [Related]

  • 39. Historical development and potential uses of tumor antigens as markers of human cancer growth.
    Gold P, Shuster J.
    Cancer Res; 1980 Aug 10; 40(8 Pt 2):2973-6. PubMed ID: 6249494
    [Abstract] [Full Text] [Related]

  • 40. Strategies for heterogeneous enzyme immunoassays for tumor markers.
    King WJ, Tomita JT, Dowell BL, Delfert DM.
    Immunol Ser; 1990 Aug 10; 53():83-93. PubMed ID: 1713072
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.